| Pharmaceutical active ingredients: |
| Ferrous Fumarate |
| Available forms, composition and doses of Palafer: |
| Capsules; Oral; Ferrous Fumarate 300 mgSuspension; Oral; Ferrous Fumarate 300 mg / 5 ml |
| Palafer medical category: |
| Human:Iron preparationsMineral supplements |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B03AA02 - Ferrous Fumarate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKline |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Oxybral SR | Vincamine | GlaxoSmithKline |
| Ozothin | Oxidation Product of Turpentine Oil Landes; Terpin Hydrate | GlaxoSmithKline |
| Ozothin Suppositories | Acetaminophen; Oxidation Product of Turpentine Oil Landes; Pine Sylvestris Oil | GlaxoSmithKline |
| Ozothin Syrup | Butetamate Citrate; Oxidation Product of Turpentine Oil Landes | GlaxoSmithKline |
| Ozothin Tablets | Dyphylline; Oxidation Product of Turpentine Oil Landes | GlaxoSmithKline |
| Palafer CF | Folic Acid; Iron (Ferrous Fumarate); Vitamin C (Ascorbic Acid) | GlaxoSmithKline |
| Pallia | Cimetidine | GlaxoSmithKline |
| Pameton | Acetaminophen; DL-Methionine | GlaxoSmithKline |
| Panadeine | Acetaminophen; Codeine Phosphate | GlaxoSmithKline; DKSH; IDS Group; Sanofi-Aventis; Zuellig Pharma |
| Panadeine Forte | Acetaminophen; Codeine Phosphate | GlaxoSmithKline; Sanofi-Aventis |